Glucose Health, Inc. 3Rd Quarter 2020 Preliminary Results Indicate 80% Revenue Increase

BENTONVILLE, Ark., Oct. 1, 2020 /PRNewswire/ -- Glucose Health, Inc. (OTC: GLUC) today advised that preliminary sales figures indicate an 80% revenue increase for the 3^rd quarter ending September 30, 2020, vs the prior quarterly period, ending September 30, 2019. This better-than-expected 80% revenue increase was driven by strong Walmart sales, but in particular, driven by unexpectedly robust sales at Amazon, despite the inventory challenges experienced during the 3^rd quarter. For most of the 3^rd quarter, two of the four flavors of GLUCODOWN® were in sold-out status at Amazon. Nevertheless, sales of the in-stock GLUCODOWN® flavors at Amazon still generated a triple-digit revenue increase for the 3^rd quarter of 2020 vs. the 3^rd quarter of 2019. Complete financial statements for Q3 2020 are expected to be posted at OTCMarkets.com on November 16, 2020.

About Glucose Health, Inc. (OTC: GLUC)

Manufactured by Glucose Health, Inc., GLUCODOWN® nutritional beverages are formulated for the diabetic/adult nutrition retail category. More than 100 million Americans are estimated to be diabetic or pre-diabetic, by the Centers for Disease Control and Prevention.¹ GLUCODOWN® provides these consumers, and increasingly many other health-conscious consumers such as followers of a KETO diet, with a nutritious, efficacious and delicious beverage option. Glucose Health, Inc. is a publicly traded company with the ticker symbol OTC: GLUC.

For more GLUC news visit www.glucosehealthinc.com

¹National Diabetes Statistics Review, 2020; Centers for Disease Control and Prevention, Department of Health and Human Services.

Contact:
Murray Fleming
Glucose Health, Inc.
[email protected]
(479) 802-3827

SOURCE Glucose Health, Inc.